The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) announced a pitch competition for COVID-19-related pediatric medical devices. The competition, which is accepting submissions from now through July 6, focuses on devices that support home health monitoring and telehealth to improve sustainability, resiliency and readiness in diagnosing and treating children during a pandemic, according to a news […]
Children's National Health System
Pediatric medical device competition extending its deadline
The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) is extending its “Make Your Medical Device Pitch for Kids” competition deadline to Aug. 24 at midnight Pacific time. “We’ve had unprecedented interest in the competition this year and we want to accommodate as many pediatric medical device innovators as possible, so we want to give […]
Children’s National Health System highlights novel approach for cell therapy
Children’s National Health System touted data today from a Phase I dose-ranging study evaluating a cell therapy approach in patients with blood and bone marrow cancers for whom stem cell transplantation hasn’t worked. Results from the Resolve trial showed that 78% of patients responded to multi-tumor-associated antigen specific lymphocytes (TAA-L) treatment and 44% of patients […]
Celsion’s ThermoDox activated by ultrasound in pediatric cancer study
Celsion (NSDQ:CLSN) and Children’s National Health System are teaming up to tackle refractory solid tumors in pediatric patients using a heat-activated chemotherapy drug and noninvasive ultrasound. The Phase I clinical trial, which launched last November, is the 1st of its kind in the U.S. Lawrenceville, N.J.-based Celsion’s ThermoDox is a heat-activated liposomal doxorubicin. In combination with MRI, […]